Redundant meta-analyses are common in genetic epidemiology.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
11 2020
Historique:
received: 06 11 2019
revised: 02 05 2020
accepted: 13 05 2020
pubmed: 17 6 2020
medline: 6 3 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

The massive growth in the publication of meta-analyses may cause redundancy and wasted efforts. We performed a metaepidemiologic study to evaluate the extent of potential redundancy in published meta-analyses in genetic epidemiology. Using a sample of 38 index meta-analyses of genetic associations published in 2010, we retrieved additional meta-analyses that evaluated identical associations (same genetic variant and phenotype) using the Human Genome Epidemiology (HuGE) Navigator and PubMed databases. We analyzed the frequency of potential duplication and examined whether subsequent meta-analyses cited previous meta-analyses on the exact same association. Based on 38 index meta-analyses, we retrieved a total of 99 duplicate meta-analyses. Only 12 (32%) of the index meta-analyses were unambiguously unique. We found a mean of 2.6 duplicates and a median of 2 duplicates per meta-analysis. In case studies, only 29-54% of previously published meta-analyses were cited by subsequent ones. These results suggest that duplication is common in meta-analyses of genetic associations.

Identifiants

pubmed: 32540390
pii: S0895-4356(19)30955-2
doi: 10.1016/j.jclinepi.2020.05.035
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-48

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Matthew K Sigurdson (MK)

Department of Health Research and Policy, Stanford University School of Medicine, Stanford University, Stanford, CA, USA; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA. Electronic address: msigurds@stanford.edu.

Muin J Khoury (MJ)

Office of Public Health Genomics, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.

John P A Ioannidis (JPA)

Department of Health Research and Policy, Stanford University School of Medicine, Stanford University, Stanford, CA, USA; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA; Department of Statistics, Stanford University School of Humanities and Science, Stanford University, Stanford, CA, USA; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford University, Stanford, CA, USA; Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH